SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.44-3.3%1:43 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sam Citron who wrote (14151)11/16/2004 3:05:42 PM
From: Biomaven  Read Replies (1) of 52153
 
Sam,

I use a program called Open Interest:

rpsw.com

It's shareware - you get some time free and then have to pony-up $250, but I think it's worth it. Very nice for modeling complex option plays.

One nice thing about the program is that it bases the implied volatility on the average bid/ask. You really have to watch out for sites that use last trade, which is often stale in the thinly traded options where we hang out, or on just the bid or ask which cna be very misleading.

The CTIC smile is very unusual. For the March and June contracts (which are the crucial ones) the implied volatility is extremely high and very flat across all strike prices. (So no smile at all). Not sure I've ever seen anything similar.

For those that that may not understand smiles, the key is that the Black-Scholes formula assumes a lognormal distribution of future stock prices. But in practice, prices have fat tales, and so lognormal isn't the right distribution. To offset this, people jack up the volatility of the strikes that are away from the money and make those options more expensive. If you plot the resulting implied volatilities you get a smile, with a low point at the current stock price and higher volatilities as you get further out.

Now with CTIC, we are going to get a dramatic move, one way or the other. The options market agrees with this, as can be seen by the incredibly high implied volatilities. But I would expect say the March 15 calls to be comparatively more expensive than the March 7.5 calls, which is not the case. So maybe a trade something like selling the March 7.5's and buying the 12.5's (in some appropriate ratio) might be interesting.

Others are welcome to chime in here. I sometimes think if I just took a couple of weeks off and really studied biotech options I could discover something luscious...

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext